EZZ Life Science Holdings Limited

Equities

EZZ

AU0000130569

Pharmaceuticals

Market Closed - Australian S.E. 01:58:49 2024-04-26 am EDT 5-day change 1st Jan Change
0.9 AUD +1.69% Intraday chart for EZZ Life Science Holdings Limited +6.51% +38.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EZZ Life's Receipts from Customers Up 111% in Fiscal Q3 MT
EZZ Life Science Completes AU$854,000 Placement with Kingstone Venture Capital MT
Renewed Rate Cut Hopes Lift Australian Shares MT
Ezz Life Science Posts 43% H1 Revenue Increase to AU$21.7 Million, EBITDA Falls 7% to AU$1.7 Million MT
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
EZZ Life Science Holdings Limited Declares Fully Franked Final Dividend for the Twelve Month Period Ended 30 June 2023, Payable on 8 December 2023 CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
EZZ Life Science Holdings Limited Announces Dividend of for the Six Months Ended December 31, 2022, Payable on June 23, 2023 CI
Ezz Life Science Declares Interim Dividend; Shares Jump 7% MT
Ezz Life Science Signs Two-Year Distribution Deal MT
EZZ Life Science Launches Amazon Online Store in Australia; Shares Up 8% MT
30,000,000 Ordinary Shares of EZZ Life Science Holdings Limited are subject to a Lock-Up Agreement Ending on 3-MAR-2023. CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
EZZ Life Science Holdings Limited Elects Qizhou Qin as Director CI
EZZ Life Science Holdings Limited Declares Fully Franked Final Dividend for the Twelve Month Period Ended 30 June 2022, Payable on 16 December 2022 CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Ezz Life Science Launches Overseas Flagship Store on Douyin Platform MT
Ezz Life Science Holdings Limited Establishes International Store on Douyin CI
EZZ Life Science Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2021 CI
EZZ Life Science Holdings Appoints Glenn Cross as Chairperson and Non-Executive Director CI
EZZ Life Science Holdings Limited Announces Appointments of Directors CI
Ezz Life Science Chair Resigns MT
EZZ Life Science Holdings Limited Announces Resignation of Philippa Lewis as Chair and Non-Executive Director CI
EZZ Life Science : CEO Resigns MT
EZZ Life Science Holdings Limited Announces Director Changes CI
Chart EZZ Life Science Holdings Limited
More charts
EZZ Life Science Holdings Limited is an Australia-based genomic life science company. The Company is engaged in research and development in genomics and precision nutrition with a focus on four human health challenges, including genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. It formulates, produces, markets and distributes health supplements under the brand of EZZ to retailers and consumers domestically and internationally. The Company is also a wholesale distributor of skin care products under the EAORON brand in Australia and New Zealand to pharmacies, supermarkets and specialist retailers. Its products under the EZZ brand include EZZ Hair Growth Spray, EZZ Hair Scrub, EZZ Hair Mask, EZZ Anti-frizz Hair Spray, EZZ Biotic Engastro Capsule, EZZ Coffee Jelly and EZZ Iron Jelly. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, herbal/ traditional and pediatric consumer health products.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. EZZ Stock
  4. News EZZ Life Science Holdings Limited
  5. Ezz Life Science Signs Two-Year Distribution Deal